Clinical Trials

Showing trials with last updates posted in 2024.

NCT04425031 | COMPLETED | PHASE4
726 participants

Handling Oxygenation Targets in COVID-19

Study Type:
INTERVENTIONAL
Last Updated:
2024-07-15
Start Date:
2020-08-25
Completion:
2023-03-08
Conditions
  • Hypoxemic Respiratory Failure
  • Oxygen Toxicity
Interventions
  • DRUG
No Results Yet
NCT03546894 | COMPLETED
111 participants

A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) Inhibitors

Study Type:
OBSERVATIONAL
Last Updated:
2024-07-15
Start Date:
2018-07-23
Completion:
2023-02-13
Conditions
  • Anaplastic Lymphoma Kinase-positive
  • Carcinoma Non-small-cell Lung
Interventions
  • DRUG
No Results Yet
NCT02429531 | COMPLETED | PHASE4
200 participants

Polysaccharide Antibody Response Study

Study Type:
INTERVENTIONAL
Last Updated:
2024-07-15
Start Date:
2015-10-31
Completion:
2018-08-31
Conditions
  • Specific Polysaccharide Antibody Deficiency
Interventions
  • BIOLOGICAL
No Results Yet
NCT01798004 | COMPLETED | PHASE1
150 participants

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Study Type:
INTERVENTIONAL
Last Updated:
2024-07-15
Start Date:
2013-04-09
Completion:
2015-07-28
Conditions
  • Ganglioneuroblastoma
  • Stage 1 Neuroblastoma
  • Stage 2 Neuroblastoma
  • Stage 2A Neuroblastoma
  • Stage 2B Neuroblastoma
  • Stage 3 Neuroblastoma
  • Stage 4 Neuroblastoma
  • Stage 4S Neuroblastoma
Interventions
  • PROCEDURE
  • DRUG
  • RADIATION
  • BIOLOGICAL
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page